Literature DB >> 9187261

2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression.

T L Yue1, X Wang, C S Louden, S Gupta, K Pillarisetti, J L Gu, T K Hart, P G Lysko, G Z Feuerstein.   

Abstract

2-Methoxyestradiol (2-ME) is an endogenous metabolite of estradiol-17beta and the oral contraceptive agent 17-ethylestradiol. 2-ME was recently reported to inhibit endothelial cell proliferation. The current study was undertaken to explore the mechanism of 2-ME effects on endothelial cells, especially whether 2-ME induces apoptosis, a prime mechanism in tissue remodeling and angiogenesis. Cultured bovine pulmonary artery endothelial cells (BPAEC) exposed to 2-ME showed morphological (including ultrastructural) features characteristic of apoptosis: cell shrinkage, cytoplasmic and nuclear condensation, and cell blebbing. 2-ME-induced apoptosis in BPAEC was a time- and concentration-dependent process (EC50 = 0.45 +/- 0.09 microM, n = 8). Nucleosomal DNA fragmentation in BPAEC treated with 2-ME was identified by agarose gel electrophoresis (DNA ladder) as well as in situ nick end labeling. Under the same experimental conditions, estradiol-17beta and two of its other metabolites, estriol and 2-methoxyestriol (< or =10 microM), did not have an apoptotic effect on BPAEC. 2-ME activated stress-activated protein kinase (SAPK)/c-Jun amino-terminal protein kinase in BPAEC in a concentration-dependent manner. The activity of SAPK was increased by 170 +/- 27% and 314 +/- 22% over the basal level in the presence of 0.4 and 2 microM 2-ME (n = 3-6), respectively. The activation of SAPK was detected at 10 min, peaked at 20 min, and returned to basal levels at 60 min after exposure to 2-ME. Inhibition of SAPK/c-Jun amino-terminal protein kinase activation by basic fibroblast growth factor, insulin-like growth factor, or forskolin reduced 2-ME-induced apoptosis. Immunohistochemical analysis of BPAEC indicated that 2-ME up-regulated expression of both Fas and Bcl-2. In addition, 2-ME inhibited BPAEC migration (IC50 = 0.71 +/- 0.11 microM, n = 4) and basic fibroblast growth factor-induced angiogenesis in the chick chorioallantoic membrane model. Taken together, these results suggest that promotion of endothelial cell apoptosis, thereby inhibiting endothelial cell proliferation and migration, may be a major mechanism by which 2-ME inhibits angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187261     DOI: 10.1124/mol.51.6.951

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

1.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

Review 2.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

3.  Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.

Authors:  Danyu Sun; Keith R McCrae
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

4.  Pregnancy ameliorates the inhibitory effects of 2-methoxyestradiol on angiogenesis in primary sheep uterine endothelial cells.

Authors:  Sana M Salih; Arvinder Kapur; Samet Albayrak; Salama A Salama; Ronald R Magness
Journal:  Reprod Sci       Date:  2011-03-18       Impact factor: 3.060

5.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

6.  Estradiol-17beta and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites stimulate proliferation in uterine artery endothelial cells: role of estrogen receptor-alpha versus estrogen receptor-beta.

Authors:  Sheikh O Jobe; Jayanth Ramadoss; Jill M Koch; Yizhou Jiang; Jing Zheng; Ronald R Magness
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

7.  Neuronal Nitric Oxide Synthase-Mediated Genotoxicity of 2-Methoxyestradiol in Hippocampal HT22 Cell Line.

Authors:  Magdalena Gorska; Michal A Zmijewski; Alicja Kuban-Jankowska; Maciej Wnuk; Iwona Rzeszutek; Michal Wozniak
Journal:  Mol Neurobiol       Date:  2015-09-17       Impact factor: 5.590

8.  Sex differences in gene expression in response to ischemia in the human left ventricular myocardium.

Authors:  Gregory Stone; Ashley Choi; Oliva Meritxell; Joshua Gorham; Mahyar Heydarpour; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Vincent J Carey; Benjamin A Raby; Barbara E Stranger; Jochen D Muehlschlegel
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

9.  2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest.

Authors:  Avudaiappan Maran; Kristen L Shogren; Michaela Benedikt; Gobinda Sarkar; Russell T Turner; Michael J Yaszemski
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

10.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.